Adenoviral-mediated transfer of the human endothelial nitric oxide synthase gene reduces acute hypoxic pulmonary vasoconstriction in rats

Stefan P. Janssens, Kenneth D. Bloch, Zengxuan Nong, Robert D. Gerard, Pierre Zoldhelyi, Desire Collen

Research output: Contribution to journalArticle

113 Citations (Scopus)

Abstract

Nitric oxide (NO), a vasodilator involved in the regulation of pulmonary vascular tone, is synthesized by a family of enzymes, nitric oxide synthases (NOS). To investigate whether adenoviral-mediated overexpression of constitutive endothelial NOS (ceNOS) would attenuate hypoxic pulmonary vasoconstriction, we aerosolized 3 x 109 plaque forming units of a recombinant adenovirus containing the ceNOS gene (AdCMVceNOS) into rat lungs. Four days after infection, transgene expression was confirmed using immunoblot techniques. Diffuse ceNOS immunostaining was detected in alveoli and medium-sized and small pulmonary vessels of AdCMVceNOS-transduced lungs. AdCMVceNOS-transduction was associated with an 86% increase in [3H]arginine to [3H]citrulline conversion and a rise in pulmonary cGMP levels from 7±1 to 59±9 pmol/mg protein in lungs from AdCMVceNOS versus control rats, (P < 0.05). During acute hypoxia (FIO2 = 0.10) for 25 min, mean pulmonary artery pressure (PAP) increased significantly from 17±1 to 27±1 mmHg in rats aerosolized with saline (n = 4) and from 18±1 to 28±1 mmHg in rats given an adenoviral vector expressing a nuclear-targeted β-galactosidase gene (AdCMVβgal, n = 8). In contrast, in AdCMVceNOS-transduced rats (n = 8) the hypoxia-induced increase in PAP was significantly attenuated (18±1 to 23±2 mmHg). Systemic blood pressure was not affected by aerosol gene transfer. Thus, adenoviral-mediated ceNOS gene transfer to rat lungs increases ceNOS expression and activity, and reduces acute hypoxic pulmonary vasoconstriction. Aerosolized recombinant adenovirus overexpressing vasodilatory proteins can act as a selective pulmonary vasodilator and may hold promise as a future therapeutic strategy for pulmonary hypertension.

Original languageEnglish (US)
Pages (from-to)317-324
Number of pages8
JournalJournal of Clinical Investigation
Volume98
Issue number2
StatePublished - Jul 15 1996

Fingerprint

Nitric Oxide Synthase Type III
Vasoconstriction
Lung
Genes
Vasodilator Agents
Adenoviridae
Pulmonary Artery
Galactosidases
Pressure
Citrulline
Aerosols
Transgenes
Pulmonary Hypertension
Nitric Oxide Synthase
Blood Vessels
Arginine
Nitric Oxide
Proteins
Blood Pressure

Keywords

  • adenovirus
  • gene therapy
  • guanylate cyclase
  • hypoxia
  • pulmonary hypertension

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Adenoviral-mediated transfer of the human endothelial nitric oxide synthase gene reduces acute hypoxic pulmonary vasoconstriction in rats. / Janssens, Stefan P.; Bloch, Kenneth D.; Nong, Zengxuan; Gerard, Robert D.; Zoldhelyi, Pierre; Collen, Desire.

In: Journal of Clinical Investigation, Vol. 98, No. 2, 15.07.1996, p. 317-324.

Research output: Contribution to journalArticle

Janssens, Stefan P. ; Bloch, Kenneth D. ; Nong, Zengxuan ; Gerard, Robert D. ; Zoldhelyi, Pierre ; Collen, Desire. / Adenoviral-mediated transfer of the human endothelial nitric oxide synthase gene reduces acute hypoxic pulmonary vasoconstriction in rats. In: Journal of Clinical Investigation. 1996 ; Vol. 98, No. 2. pp. 317-324.
@article{821fccc594d341d99fe67cb3765ec661,
title = "Adenoviral-mediated transfer of the human endothelial nitric oxide synthase gene reduces acute hypoxic pulmonary vasoconstriction in rats",
abstract = "Nitric oxide (NO), a vasodilator involved in the regulation of pulmonary vascular tone, is synthesized by a family of enzymes, nitric oxide synthases (NOS). To investigate whether adenoviral-mediated overexpression of constitutive endothelial NOS (ceNOS) would attenuate hypoxic pulmonary vasoconstriction, we aerosolized 3 x 109 plaque forming units of a recombinant adenovirus containing the ceNOS gene (AdCMVceNOS) into rat lungs. Four days after infection, transgene expression was confirmed using immunoblot techniques. Diffuse ceNOS immunostaining was detected in alveoli and medium-sized and small pulmonary vessels of AdCMVceNOS-transduced lungs. AdCMVceNOS-transduction was associated with an 86{\%} increase in [3H]arginine to [3H]citrulline conversion and a rise in pulmonary cGMP levels from 7±1 to 59±9 pmol/mg protein in lungs from AdCMVceNOS versus control rats, (P < 0.05). During acute hypoxia (FIO2 = 0.10) for 25 min, mean pulmonary artery pressure (PAP) increased significantly from 17±1 to 27±1 mmHg in rats aerosolized with saline (n = 4) and from 18±1 to 28±1 mmHg in rats given an adenoviral vector expressing a nuclear-targeted β-galactosidase gene (AdCMVβgal, n = 8). In contrast, in AdCMVceNOS-transduced rats (n = 8) the hypoxia-induced increase in PAP was significantly attenuated (18±1 to 23±2 mmHg). Systemic blood pressure was not affected by aerosol gene transfer. Thus, adenoviral-mediated ceNOS gene transfer to rat lungs increases ceNOS expression and activity, and reduces acute hypoxic pulmonary vasoconstriction. Aerosolized recombinant adenovirus overexpressing vasodilatory proteins can act as a selective pulmonary vasodilator and may hold promise as a future therapeutic strategy for pulmonary hypertension.",
keywords = "adenovirus, gene therapy, guanylate cyclase, hypoxia, pulmonary hypertension",
author = "Janssens, {Stefan P.} and Bloch, {Kenneth D.} and Zengxuan Nong and Gerard, {Robert D.} and Pierre Zoldhelyi and Desire Collen",
year = "1996",
month = "7",
day = "15",
language = "English (US)",
volume = "98",
pages = "317--324",
journal = "Journal of Clinical Investigation",
issn = "0021-9738",
publisher = "The American Society for Clinical Investigation",
number = "2",

}

TY - JOUR

T1 - Adenoviral-mediated transfer of the human endothelial nitric oxide synthase gene reduces acute hypoxic pulmonary vasoconstriction in rats

AU - Janssens, Stefan P.

AU - Bloch, Kenneth D.

AU - Nong, Zengxuan

AU - Gerard, Robert D.

AU - Zoldhelyi, Pierre

AU - Collen, Desire

PY - 1996/7/15

Y1 - 1996/7/15

N2 - Nitric oxide (NO), a vasodilator involved in the regulation of pulmonary vascular tone, is synthesized by a family of enzymes, nitric oxide synthases (NOS). To investigate whether adenoviral-mediated overexpression of constitutive endothelial NOS (ceNOS) would attenuate hypoxic pulmonary vasoconstriction, we aerosolized 3 x 109 plaque forming units of a recombinant adenovirus containing the ceNOS gene (AdCMVceNOS) into rat lungs. Four days after infection, transgene expression was confirmed using immunoblot techniques. Diffuse ceNOS immunostaining was detected in alveoli and medium-sized and small pulmonary vessels of AdCMVceNOS-transduced lungs. AdCMVceNOS-transduction was associated with an 86% increase in [3H]arginine to [3H]citrulline conversion and a rise in pulmonary cGMP levels from 7±1 to 59±9 pmol/mg protein in lungs from AdCMVceNOS versus control rats, (P < 0.05). During acute hypoxia (FIO2 = 0.10) for 25 min, mean pulmonary artery pressure (PAP) increased significantly from 17±1 to 27±1 mmHg in rats aerosolized with saline (n = 4) and from 18±1 to 28±1 mmHg in rats given an adenoviral vector expressing a nuclear-targeted β-galactosidase gene (AdCMVβgal, n = 8). In contrast, in AdCMVceNOS-transduced rats (n = 8) the hypoxia-induced increase in PAP was significantly attenuated (18±1 to 23±2 mmHg). Systemic blood pressure was not affected by aerosol gene transfer. Thus, adenoviral-mediated ceNOS gene transfer to rat lungs increases ceNOS expression and activity, and reduces acute hypoxic pulmonary vasoconstriction. Aerosolized recombinant adenovirus overexpressing vasodilatory proteins can act as a selective pulmonary vasodilator and may hold promise as a future therapeutic strategy for pulmonary hypertension.

AB - Nitric oxide (NO), a vasodilator involved in the regulation of pulmonary vascular tone, is synthesized by a family of enzymes, nitric oxide synthases (NOS). To investigate whether adenoviral-mediated overexpression of constitutive endothelial NOS (ceNOS) would attenuate hypoxic pulmonary vasoconstriction, we aerosolized 3 x 109 plaque forming units of a recombinant adenovirus containing the ceNOS gene (AdCMVceNOS) into rat lungs. Four days after infection, transgene expression was confirmed using immunoblot techniques. Diffuse ceNOS immunostaining was detected in alveoli and medium-sized and small pulmonary vessels of AdCMVceNOS-transduced lungs. AdCMVceNOS-transduction was associated with an 86% increase in [3H]arginine to [3H]citrulline conversion and a rise in pulmonary cGMP levels from 7±1 to 59±9 pmol/mg protein in lungs from AdCMVceNOS versus control rats, (P < 0.05). During acute hypoxia (FIO2 = 0.10) for 25 min, mean pulmonary artery pressure (PAP) increased significantly from 17±1 to 27±1 mmHg in rats aerosolized with saline (n = 4) and from 18±1 to 28±1 mmHg in rats given an adenoviral vector expressing a nuclear-targeted β-galactosidase gene (AdCMVβgal, n = 8). In contrast, in AdCMVceNOS-transduced rats (n = 8) the hypoxia-induced increase in PAP was significantly attenuated (18±1 to 23±2 mmHg). Systemic blood pressure was not affected by aerosol gene transfer. Thus, adenoviral-mediated ceNOS gene transfer to rat lungs increases ceNOS expression and activity, and reduces acute hypoxic pulmonary vasoconstriction. Aerosolized recombinant adenovirus overexpressing vasodilatory proteins can act as a selective pulmonary vasodilator and may hold promise as a future therapeutic strategy for pulmonary hypertension.

KW - adenovirus

KW - gene therapy

KW - guanylate cyclase

KW - hypoxia

KW - pulmonary hypertension

UR - http://www.scopus.com/inward/record.url?scp=0030017320&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030017320&partnerID=8YFLogxK

M3 - Article

C2 - 8755640

AN - SCOPUS:0030017320

VL - 98

SP - 317

EP - 324

JO - Journal of Clinical Investigation

JF - Journal of Clinical Investigation

SN - 0021-9738

IS - 2

ER -